Molecular Classification of Triple-Negative Breast Cancer

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Triple-negative breast cancer (TNBC) exhibits significant tumor heterogeneity, impeding effective treatment strategies.
• Understanding TNBC's molecular diversity is crucial for identifying novel therapeutic targets and improving patient outcomes.
• Current research prioritizes molecular classification to address the complexities of TNBC.

Approach:

• This review analyzes diverse methodologies employed in classifying TNBC subtypes.
• It synthesizes findings from recent studies that have successfully categorized TNBC into distinct molecular subtypes.
• The focus is on identifying commonalities and discrepancies across different classification systems.

Key Points:

• TNBC is characterized by substantial molecular heterogeneity, posing a significant barrier to treatment.
• Despite varied approaches, studies consistently identify four major TNBC subtypes: basal-like, mesenchymal, luminal androgen receptor, and immune-enriched.
• These subtypes are associated with distinct biological pathways and potential therapeutic vulnerabilities.

Conclusions:

• The classification of TNBC into distinct molecular subtypes is a critical step towards personalized medicine.
• A significant unmet need exists for a standardized molecular classifier tailored specifically for TNBC.
• Developing such a classifier will facilitate targeted therapeutic development and enhance treatment efficacy for TNBC patients.